A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma
Clinical trial NCT00192088 · COMPLETED
Trial details
- NCT number
- NCT00192088
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.